Andreana Benitez1,2,3, Jens H Jensen2,4, Kathryn Thorn1,4, Siddhartha Dhiman4, Stephanie Fountain-Zaragoza1,2, William J Rieter3, Maria Vittoria Spampinato3, Eric D Hamlett5, Paul J Nietert6, Maria de Fatima Falangola2,4, Joseph A Helpern2,4. 1. Department of Neurology, Medical University of South Carolina, Charleston, SC, USA. 2. Center for Biomedical Imaging, Medical University of South Carolina, Charleston, SC, USA. 3. Department of Radiology and Radiological Sciences, Medical University of South Carolina, Charleston, SC, USA. 4. Department of Neuroscience, Medical University of South Carolina, Charleston, SC, USA. 5. Department of Pathology and Laboratory Sciences, Medical University of South Carolina, Charleston, SC, USA. 6. Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
Abstract
OBJECTIVE: The Alzheimer's continuum is biologically defined by beta-amyloid deposition, which at the earliest stages is superimposed upon white matter degeneration in aging. However, the extent to which these co-occurring changes is characterized is relatively underexplored. The goal of this study was to use diffusional kurtosis imaging (DKI) and biophysical modeling to detect and describe amyloid-related white matter changes in preclinical Alzheimer disease. METHODS: Cognitively unimpaired participants ages 45 to 85 years completed brain magnetic resonance imaging, amyloid positron emission tomography (florbetapir), neuropsychological testing, and other clinical measures at baseline in a cohort study. We tested whether beta-amyloid-negative (AB-) and -positive (AB+) participants differed on DKI-based conventional (ie, fractional anisotropy [FA], mean diffusivity [MD], mean kurtosis) and modeling (ie, axonal water fraction [AWF], extra-axonal radial diffusivity [De,⊥ ]) metrics, and whether these metrics were associated with other biomarkers. RESULTS: We found significantly greater diffusion restriction (higher FA/AWF, lower MD/De,⊥ ) in white matter in AB+ than AB- (partial η2 =0.08-0.19), more notably in the extra-axonal space within primarily late myelinating tracts. Diffusion metrics predicted amyloid status incrementally over age (area under the curve = 0.84) with modest yet selective associations, where AWF (a marker of axonal density) correlated with speed/executive functions and neurodegeneration, whereas De,⊥ (a marker of gliosis/myelin repair) correlated with amyloid deposition and white matter hyperintensity volume. INTERPRETATION: These results support prior evidence of a nonmonotonic change in diffusion behavior, where an early increase in diffusion restriction is hypothesized to reflect inflammation and myelin repair prior to an ensuing decrease in diffusion restriction, indicating glial and neuronal degeneration. ANN NEUROL 2022;91:864-877.
OBJECTIVE: The Alzheimer's continuum is biologically defined by beta-amyloid deposition, which at the earliest stages is superimposed upon white matter degeneration in aging. However, the extent to which these co-occurring changes is characterized is relatively underexplored. The goal of this study was to use diffusional kurtosis imaging (DKI) and biophysical modeling to detect and describe amyloid-related white matter changes in preclinical Alzheimer disease. METHODS: Cognitively unimpaired participants ages 45 to 85 years completed brain magnetic resonance imaging, amyloid positron emission tomography (florbetapir), neuropsychological testing, and other clinical measures at baseline in a cohort study. We tested whether beta-amyloid-negative (AB-) and -positive (AB+) participants differed on DKI-based conventional (ie, fractional anisotropy [FA], mean diffusivity [MD], mean kurtosis) and modeling (ie, axonal water fraction [AWF], extra-axonal radial diffusivity [De,⊥ ]) metrics, and whether these metrics were associated with other biomarkers. RESULTS: We found significantly greater diffusion restriction (higher FA/AWF, lower MD/De,⊥ ) in white matter in AB+ than AB- (partial η2 =0.08-0.19), more notably in the extra-axonal space within primarily late myelinating tracts. Diffusion metrics predicted amyloid status incrementally over age (area under the curve = 0.84) with modest yet selective associations, where AWF (a marker of axonal density) correlated with speed/executive functions and neurodegeneration, whereas De,⊥ (a marker of gliosis/myelin repair) correlated with amyloid deposition and white matter hyperintensity volume. INTERPRETATION: These results support prior evidence of a nonmonotonic change in diffusion behavior, where an early increase in diffusion restriction is hypothesized to reflect inflammation and myelin repair prior to an ensuing decrease in diffusion restriction, indicating glial and neuronal degeneration. ANN NEUROL 2022;91:864-877.
Authors: M I Kamboh; M M Barmada; F Y Demirci; R L Minster; M M Carrasquillo; V S Pankratz; S G Younkin; A J Saykin; R A Sweet; E Feingold; S T DeKosky; O L Lopez Journal: Mol Psychiatry Date: 2011-10-18 Impact factor: 15.992
Authors: Marion Mortamais; Jessica A Ash; John Harrison; Jeffrey Kaye; Joel Kramer; Christopher Randolph; Carine Pose; Bruce Albala; Michael Ropacki; Craig W Ritchie; Karen Ritchie Journal: Alzheimers Dement Date: 2016-10-01 Impact factor: 21.566
Authors: Hartmut B F Pohl; Cristina Porcheri; Thomas Mueggler; Lukas C Bachmann; Gianvito Martino; Dieter Riethmacher; Robin J M Franklin; Markus Rudin; Ueli Suter Journal: J Neurosci Date: 2011-01-19 Impact factor: 6.167
Authors: Peisu Zhang; Yuki Kishimoto; Ioannis Grammatikakis; Kamalvishnu Gottimukkala; Roy G Cutler; Shiliang Zhang; Kotb Abdelmohsen; Vilhelm A Bohr; Jyoti Misra Sen; Myriam Gorospe; Mark P Mattson Journal: Nat Neurosci Date: 2019-04-01 Impact factor: 24.884
Authors: Douglas C Dean; Samuel A Hurley; Steven R Kecskemeti; J Patrick O'Grady; Cristybelle Canda; Nancy J Davenport-Sis; Cynthia M Carlsson; Henrik Zetterberg; Kaj Blennow; Sanjay Asthana; Mark A Sager; Sterling C Johnson; Andrew L Alexander; Barbara B Bendlin Journal: JAMA Neurol Date: 2017-01-01 Impact factor: 18.302
Authors: Maria Fatima Falangola; Xingju Nie; Ralph Ward; Emilie T McKinnon; Siddhartha Dhiman; Paul J Nietert; Joseph A Helpern; Jens H Jensen Journal: NMR Biomed Date: 2020-06-17 Impact factor: 4.044
Authors: Nicholas M Vogt; Jack F V Hunt; Nagesh Adluru; Yue Ma; Carol A Van Hulle; Douglas C Dean Iii; Steven R Kecskemeti; Nathaniel A Chin; Cynthia M Carlsson; Sanjay Asthana; Sterling C Johnson; Gwendlyn Kollmorgen; Richard Batrla; Norbert Wild; Katharina Buck; Henrik Zetterberg; Andrew L Alexander; Kaj Blennow; Barbara B Bendlin Journal: Alzheimers Dement Date: 2021-05-13 Impact factor: 16.655
Authors: Xinwen Zhang; Rihua Wang; Di Hu; Xiaoyan Sun; Hisashi Fujioka; Kathleen Lundberg; Ernest R Chan; Quanqiu Wang; Rong Xu; Margaret E Flanagan; Andrew A Pieper; Xin Qi Journal: Sci Adv Date: 2020-12-04 Impact factor: 14.957